There were statistically significant differences in the expression of glioma grades (WHO II, WHO III, and WHO IV) (P < 0.001) [Figure 3A and B], as well as statistically significant differences among different states of isocitrate dehydrogenase (IDH) (wild type, mutant type) (P < 0.001). This evidence concerns the gene IDH3A and glioma.